Basic Information
ID: ALA5136653
Type: Functional
Description: Antiviral activity against SARS-COV 2 infected in human Calu-3 cells assessed as inhibition of viral replication preincubated for 1 hr followed by viral infection and further incubated with compound for 24 hrs
Format: BAO_0000218
Organism: Severe acute respiratory syndrome coronavirus 2
Cell type: Calu-3
Target: SARS-CoV-2(ALA4303835)
Document: ALA5131566
Antiviral activity against SARS-COV 2 infected in human Calu-3 cells assessed as inhibition of viral replication preincubated for 1 hr followed by viral infection and further incubated with compound for 24 hrs: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA5136653
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 272.69 | 3.44 | 3.44 |
| 602.59 | 2.31 | 2.31 |
| 302.38 | 4.04 | 4.04 |
| 255.30 | 2.89 | 2.89 |
| 275.36 | 3.26 | 3.26 |
| 286.38 | 3.93 | 3.93 |
| 310.40 | 4.71 | 4.71 |
| 275.36 | 3.26 | 3.26 |
| 289.39 | 3.27 | 3.27 |
| 291.36 | 2.96 | 2.96 |
| 261.33 | 2.95 | 2.95 |
| 269.33 | 3.20 | 3.20 |